ArticleHealth care financing review2009
Linking tumor registry and Medicaid claims to evaluate cancer care delivery.
Article in Health care financing review, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Cancer information and population health resource: a resource for catchment area data and cancer outcomes research.JNCI cancer spectrum · 2024Article
- Comparison of primary payer in cancer registry and discharge data.The American journal of managed care · 2023Article
- Development and Evaluation of a Process to Link Cancer Patients in the SEER Registries to National Medicaid Enrollment Data.Journal of the National Cancer Institute. Monographs · 2020Article
- Review
- Temporal trends, patterns, and predictors of preterm birth in California from 2007 to 2016, based on the obstetric estimate of gestational age.Maternal health, neonatology and perinatology · 2018Article
- Data systems and record linkage: considerations for pharmacoepidemiologic studies examining cancer risk.Annals of epidemiology · 2016Article
- The impact of continuous Medicaid enrollment on diagnosis, treatment, and survival in six surgical cancers.Health services research · 2014Article
- Economic studies in colorectal cancer: challenges in measuring and comparing costs.Journal of the National Cancer Institute. Monographs · 2013Review
- Linking Medicare, Medicaid, and cancer registry data to study the burden of cancers in West Virginia.Medicare & medicaid research review · 2012Article
- Economic burden of cancer in the United States: estimates, projections, and future research.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2011Article
- Late GI and bladder toxicities after radiation for uterine cancer.Gynecologic oncology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The utility of Medicaid claims for studying cancer care is not known. Our objective was to evaluate how well Medicaid claims capture diagnostic and treatment information recorded by the California Cancer Registry (CCR). We compared cancer treatment from Medicaid claims with CCR data, using 1988-2000 cases matched with 1997-1998 Medicaid enrollment data. Medicaid claims corroborated diagnoses for 73 percent of breast and 68 percent of colorectal cancers in CCR. Medicaid claims confirmed surgery for 67 percent of CCR's breast cancers. We found that Medicaid claims have moderate sensitivity for identifying cancer diagnoses and surgery. Linked registry-Medicaid data can identify indigent patients and the timing of Medicaid coverage.
Indexed as
Identifiers
19719033PMC4195063What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.